NuWave Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $65K | Buy |
+761
| New | +$65K | 0.07% | 230 |
|
|
2022
Q2 | – | Sell |
-1,488
| Closed | -$115K | – | 261 |
|
|
2022
Q1 | $115K | Buy |
1,488
+628
| +73% | +$48.5K | 0.15% | 174 |
|
|
2021
Q4 | $76K | Buy |
+860
| New | +$76K | 0.09% | 219 |
|
|
2021
Q3 | – | Sell |
-2,527
| Closed | -$211K | – | 305 |
|
|
2021
Q2 | $211K | Buy |
2,527
+83
| +3% | +$6.93K | 0.23% | 139 |
|
|
2021
Q1 | $185K | Buy |
2,444
+2,068
| +550% | +$157K | 0.23% | 147 |
|
|
2020
Q4 | $33K | Sell |
376
-4,380
| -92% | -$384K | 0.04% | 266 |
|
|
2020
Q3 | $361K | Buy |
4,756
+4,728
| +16,886% | +$359K | 0.55% | 55 |
|
|
2020
Q2 | $3K | Buy |
+28
| New | +$3K | ﹤0.01% | 382 |
|
|
2020
Q1 | – | Sell |
-63
| Closed | -$5K | – | 224 |
|
|
2019
Q4 | $5K | Sell |
63
-2,873
| -98% | -$228K | ﹤0.01% | 369 |
|
|
2019
Q3 | $198K | Buy |
2,936
+2,750
| +1,478% | +$185K | 0.2% | 147 |
|
|
2019
Q2 | $16K | Sell |
186
-3,500
| -95% | -$301K | 0.02% | 317 |
|
|
2019
Q1 | $327K | Buy |
3,686
+3,591
| +3,780% | +$319K | 0.38% | 93 |
|
|
2018
Q4 | $8K | Sell |
95
-1,628
| -94% | -$137K | 0.01% | 274 |
|
|
2018
Q3 | $167K | Buy |
1,723
+1,719
| +42,975% | +$167K | 0.25% | 140 |
|
|
2018
Q2 | $0 | Buy |
+4
| New | – | ﹤0.01% | 385 |
|
|
2018
Q1 | – | Sell |
-13
| Closed | -$1K | – | 241 |
|
|
2017
Q4 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 327 |
|